In a recently completed project at Queen Alexandra Hospital in Portsmouth, twice as many stroke patients received the correct atrial fibrillation (AF) diagnosis with thumb-ECG (Zenicor) compared to current standard of care. The aim of the project was to develop and improve the diagnosis of AF for stroke patients in Portsmouth and to prevent recurrent strokes. The study was presented recently at the European Stroke Organisation Conference, Venice, Italy.
The thumb-ECG device has been used at Queen Alexandra Hospital in Portsmouth by 70 stroke patients over six months. The patients were investigated with thumb-ECG for three weeks in combination with continuous 24 hours Holter-ECG. With thumb-ECG, 14% of the patients were diagnosed with AF but only 7% were detected with the Holter ECG. The results are consistent with previous research from Sweden, where 7–11% of AF has been diagnosed with thumb-ECG and 1.5–4% with Holter-ECG.
Project lead Dr Ugnius Sukys (Queen Alexandra Hospital, Portsmouth) said: “We could repeat the results from the Swedish studies, and the investigation with Zenicor thumb-ECG even proved to be more effective in the Portsmouth population of stroke patients. We detected AF in a number of patients who would have been missed otherwise, and could therefore provide a better treatment for our stroke patients”.